Kuba - hiszpański - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

ferring gmbh. - triptorelina (eq. a 100 µg de acetato de triptorelina) - solución para inyección sc - 95,6 µg

Unia Europejska - hiszpański - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacunas - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.

Hiszpania - hiszpański - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

nycomed gmbh - ciclesonida - excipientes: etanol anhidro - otros agentes contra padecimientos obstructivos de las vÍas respiratorias, inhalatorios - glucocortocoides - ciclesonida

Hiszpania - hiszpański - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

nycomed gmbh - ciclesonida - excipientes: etanol anhidro - otros agentes contra padecimientos obstructivos de las vÍas respiratorias, inhalatorios - glucocortocoides - ciclesonida

Hiszpania - hiszpański - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

aristo pharma gmbh - alfuzosina hidrocloruro - comprimido de liberaciÓn prolongada - 10 mg - alfuzosina hidrocloruro 10 mg - alfuzosina

Hiszpania - hiszpański - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

glenwood gmbh pharmazeutische erzeugnisse - clonidina hidrocloruro - comprimido - 0,15 mg - clonidina hidrocloruro 0,15 mg - clonidina

Hiszpania - hiszpański - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

torrent pharma gmbh / timm juergensen - esomeprazol magnesico - excipientes: azucar , esferas de,lactosa monohidrato,almidon de maiz - agentes contra la Úlcera pÉptica y el reflujo gastroesofÁgico (rge/gord) - inhibidores de la bomba de protones - esomeprazol

Hiszpania - hiszpański - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

torrent pharma gmbh / timm juergensen - esomeprazol magnesico - excipientes: azucar , esferas de,lactosa monohidrato,almidon de maiz - agentes contra la Úlcera pÉptica y el reflujo gastroesofÁgico (rge/gord) - inhibidores de la bomba de protones - esomeprazol

Hiszpania - hiszpański - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

tillotts pharma gmbh - budesonida - cÁpsula dura de liberaciÓn modificada - 3 mg - budesonida 3 mg - budesonida

Hiszpania - hiszpański - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

tillotts pharma gmbh - budesonida - comprimido y disolvente para suspensiÓn rectal - 2 mg - budesonida 2 mg - budesonida